全文获取类型
收费全文 | 580篇 |
免费 | 26篇 |
国内免费 | 5篇 |
专业分类
儿科学 | 59篇 |
妇产科学 | 13篇 |
基础医学 | 39篇 |
临床医学 | 70篇 |
内科学 | 51篇 |
皮肤病学 | 3篇 |
神经病学 | 1篇 |
特种医学 | 24篇 |
外科学 | 208篇 |
综合类 | 44篇 |
预防医学 | 5篇 |
眼科学 | 5篇 |
药学 | 55篇 |
中国医学 | 27篇 |
肿瘤学 | 7篇 |
出版年
2023年 | 6篇 |
2022年 | 11篇 |
2021年 | 20篇 |
2020年 | 13篇 |
2019年 | 19篇 |
2018年 | 17篇 |
2017年 | 11篇 |
2016年 | 21篇 |
2015年 | 16篇 |
2014年 | 26篇 |
2013年 | 39篇 |
2012年 | 18篇 |
2011年 | 30篇 |
2010年 | 22篇 |
2009年 | 28篇 |
2008年 | 29篇 |
2007年 | 33篇 |
2006年 | 34篇 |
2005年 | 25篇 |
2004年 | 27篇 |
2003年 | 19篇 |
2002年 | 14篇 |
2001年 | 16篇 |
2000年 | 10篇 |
1999年 | 13篇 |
1998年 | 6篇 |
1997年 | 10篇 |
1996年 | 7篇 |
1995年 | 9篇 |
1994年 | 7篇 |
1993年 | 6篇 |
1992年 | 5篇 |
1990年 | 2篇 |
1989年 | 2篇 |
1988年 | 6篇 |
1987年 | 5篇 |
1986年 | 4篇 |
1985年 | 2篇 |
1981年 | 2篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1973年 | 3篇 |
1971年 | 1篇 |
1970年 | 1篇 |
1969年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有611条查询结果,搜索用时 15 毫秒
1.
Sami Al-Said Ammar Ali Abdul Kader Alobaidy Emad Mojeeb Abdulla Al-Naimi Ahmed A Shokeir 《International journal of urology》2007,14(5):452-454
Xanthogranulomatous orchitis is an extremely rare inflammatory non-neoplastic destructive lesion of the testis. We report a 44-year-old man who presented with right scrotal swelling and two discharging sinuses. Testicular tumor markers were normal. Scrotal ultrasound showed heterogeneous testicular areas and irregular margin of the tunica. Surgical exploration revealed infected, unhealthy testicular tissue with necrosis and tumor-like lesion. Orchidectomy was done and histopathology showed xanthogranulomatous orchitis. 相似文献
2.
Clinicopathological study of vesicoureteral reflux (VUR)-associated pyelonephritis in renal transplantation 总被引:1,自引:0,他引:1
K Ohba M Matsuo M Noguchi M Nishikido S Koga H Kanetake A Nazneen D Liu M S Razzaque T Taguchi 《Clinical transplantation》2004,18(S11):34-38
Abstract: We retrospectively studied the occurrence of vesicoureteral reflux (VUR)-associated pyelonephritis using renal biopsies obtained from the transplanted kidneys, and correlated the histological changes with clinical parameters. Out of a total of 131 renal biopsies performed between 1990 and 2001 on renal transplant patients at the department of Urology of Nagasaki University Graduate School of Biomedical Sciences, 12 patients showed pyuria more than twice in a single year. Seven of these 12 patients were available for determining VUR by voiding cystourethrography (VCUG). Cystoureterography demonstrated VUR in three of seven studied patients with pyuria. A histopathological examination revealed dilatation of both proximal and distal tubules in renal biopsies of transplant patients with VUR, compared to renal biopsies of transplant patients without VUR, or non-transplanted patients with thin membrane disease. One of the patients with VUR showed advanced features of chronic pyelonephritis in four consecutive biopsies at different time points, suggesting a late stage of reflux nephropathy in the transplanted kidney. We conclude from our study that the occurrence of VUR-related pyelonephritis may be one of the important long-term complications in the survival of renal allografts. 相似文献
3.
SEZGIN GUVEL FERHAT KILINC FAZILET KAYASELCUK ILHAN TUNCER HAKAN OZKARDES 《International journal of urology》2003,10(7):404-406
Emphysematous pyelonephritis is an uncommon and life-threatening infection of the kidney that is characterized by gas formation within or around the kidney and is associated with diabetes mellitus and urinary tract infection. Amoebiasis is a protozoal infection caused by Entamoeba histolytica. In its invasive forms, the disease is characterized by visceral abscess formations. We present a case of concomitant emphysematous pyelonephritis and renal amoebiasis in a 42-year-old female with uncontrolled diabetes mellitus. The patient did not respond well to initial supportive treatment and antibiotherapy. Therefore, nephrectomy was performed. She did extremely well after the operation and was discharged with antidiabetics and antibiotics. 相似文献
4.
Coexistence of renal replacement lipomatosis with xanthogranulomatous pyelonephritis 总被引:1,自引:0,他引:1
YUKO SAKATA NOBUTAKA KINOSHITA HIROMI KATO YASUSHI YAMADA YOSHIKI SUGIMURA 《International journal of urology》2004,11(1):44-46
We report on a case of coexistence of replacement lipomatosis with xanthogranulomatous pyelonephritis (XGP) in the same kidney associated with staghorn calculi. A 63-year-old man was admitted to hospital complaining of a right abdominal mass. Computed tomography (CT) showed renal parenchymal atrophy with extremely increased perirenal fat. Right nephrectomy was performed. Postoperative diagnosis was renal replacement lipomatosis with XGP. Renal replacement lipomatosis and XGP have several similarities in terms of clinical background and CT findings. Sometimes it is difficult to differentiate them from malignant diseases. It is extremely rare that both conditions coexist in the same kidney. To our knowledge, only one such case has been reported. 相似文献
5.
益肾清利化瘀汤对急性肾盂肾炎大鼠病理改变的影响 总被引:3,自引:0,他引:3
目的 探讨益肾清利化瘀汤治疗尿路感染的实验室依据。方法 建立急性肾孟肾炎大鼠模型,以左氧氟沙星为对照,观察益肾清利化瘀汤对该模型的肾脏病理学改变的影响。结果 与模型组相比,益肾清利化瘀汤组和左氧氟沙星组肾孟炎症较轻,表现在肾脏纵切面仅见有粘膜充血,第7、15天肾孟粘膜病理和间质区较少的灶性淋巴细胞浸润;而模型组可见到肾包膜紧张和肾孟扩张,以及光镜下明显的灶性淋巴细胞浸润。结论 益肾清利化瘀汤能部分减轻该模型的急性肾孟炎症。 相似文献
6.
Two cases of xanthogranulomatous pyelonephritis (XGP) are presented with emphasis on MR appearances. One case is the diffuse
type of XGP secondary to chronic obstruction caused by transitional cell carcinoma of the renal pelvis. The other case is
the focal or “tumefactive” type of XGP which mimics renal cell carcinoma.
Received: 15 February 1999; Revised: 14 June 1999; Accepted: 8 July 1999 相似文献
7.
《Current medical research and opinion》2013,29(5):394-400
SummaryForty-two patients with a radiologically confirmed diagnosis of chronic pyelonephritis were treated with 1 g carindacillin every 6 hours over a period of 6 weeks. An underlying urological disease was present in 84% of the 38 patients for whom sufficient data were available for evaluation. The results of carindacillin treatment, as judged by bacteriological evaluation I month post-treatment, were good in 12 (32%) and moderate in 9 of the patients. This success rate was remarkable in that all of the patients had been treated previously with one or more other antibiotics and chemo-therapeutic agents with little or no response. The authors recommend that, because carindacillin has proved so valuable in treating chronic as well as acute urinary tract infections, its use should be limited to patients with serious disease who have not responded to other treatment. 相似文献
8.
《Surgical pathology clinics》2014,7(3):307-319
This review discusses the pathology of non-neoplastic kidney disease that pathologists may encounter as nephrectomy specimens. The spectrum of pediatric disease is emphasized. Histopathologic assessment of non-neoplastic nephrectomy specimens must be interpreted in the clinical context for accurate diagnosis. Although molecular pathology is not the primary focus of this review, the genetics underlying several of these diseases are also touched on. 相似文献
9.
Ilias Karaiskos Maria Souli Helen Giamarellou 《Expert opinion on investigational drugs》2015,24(11):1501-1511
Introduction: Living in the ever-expanding era of multidrug-resistant (MDR), extensively drug-resistant (XDR), and even pandrug-resistant Gram-negative microorganisms, the medical community is facing the approaching fear of the “End of Antibiotics.” Plazomicin is a next-generation aminoglycoside designed to evade all clinically relevant aminoglycoside-modifying enzymes, the main mechanism of aminoglycoside resistance. A newer aminoglycoside active against several MDR-XDR microorganisms is herein presented and discussed.Areas covered: Herein, the authors present the currently available information on plazomicin. This includes the current knowledge concerning plazomicin’s: mechanisms of action, in vitro activity and interactions, its pharmacokinetics, its clinical efficacy in complicated urinary tract infections (cUTIs) and acute pyelonephritis, and its toxicity issues.Expert opinion: Plazomicin was developed to evade all clinically relevant aminoglycoside-modifying enzymes. Unfortunately, ribosomal enzymatic modification by ribosomal 16S-rRNA methyltransferases confers broad-spectrum high-level aminoglycoside resistance. Still, plazomicin demonstrates high activity against the Enterobacteriaceae including extended spectrum beta lactamase and most carbapenemase producers, as well as several of the non-fermenters. When compared to levofloxacin, the in vivo activity of plazomicin in complicated urinary tract infections (cUTIs) and in acute pyelonephritis in humans was very promising. Furthermore, regarding safety, no clinically significant effects on renal, vestibular, or cochlear function have been observed both at Phase I and II studies in humans, with mild to moderate adverse events being dose related. However, the authors believe that the real position of plazomicin in the MDR-XDR world will be revealed once pending Phase III studies are completed. 相似文献
10.
Martti Vaara 《Medicinal research reviews》2018,38(5):1661-1673
Polymyxin B and colistin (polymyxin E) are bactericidal pentacationic lipopeptides that act specifically on Gram‐negative bacteria, first by disrupting their outermost permeability barrier, the outer membrane (OM), and then damaging the cytoplasmic membrane. The discovery of both polymyxin B and colistin was published independently by three laboratories as early as in 1947. They were subsequently used in intravenous therapy. Unfortunately, they also exhibit significant and dose‐limiting nephrotoxicity. Therefore, polymyxins were reserved as agents of last‐line defense. The emergence of extremely multiresistant strains has now forced clinicians to reinstate polymyxins in the therapy of severe infections. However, the current dosage regimens lead to insufficient drug concentrations in serum and clinicians have been advised to use larger doses, which further increases the risk of nephrotoxicity. Very recently, the interest in developing better tolerated and more effective polymyxins has grown. This review focuses on describing four development programs that have yielded novel derivatives that are more effective than the old polymyxins in animal infection models. Compounds from three programs are superior to the old polymyxins in the rodent lung infection model with Acinetobacter baumannii and/or Pseudomonas aeruginosa. One of them is also more effective than polymyxin B in A. baumannii mouse thigh infection. The fourth program includes compounds that are approximately tenfold more effective in Escherichia coli murine pyelonephritis than polymyxin B. 相似文献